MedTrace Logo

New Technologies for Endoscopic Treatment of Bleeding Gastroduodenal Ulcers

NCT04239118 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2020-01-23

No results posted yet for this study

Summary

The purpose of the study was to improve treatment results of patients with bleeding gastroduodenal ulcers by endoscopic applications of autoplasma, enriched with platelets and granular sorbent aseptisorb-A.

Conditions

  • Ulcer Hemorrhage

Interventions

COMBINATION_PRODUCT

Complex endoscopic treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets

Complex endoscopic bleeding ulcers treatment with the use of granular sorbent aseptisorb-A and autoplasm enriched with platelets

PROCEDURE

Traditional methods of endoscopic hemostasis

Traditional methods of endoscopic hemostasis were used without the use of platelet-enriched plasma and granular sorbents

Sponsors & Collaborators

  • Voronezh N.N. Burdenko State Medical Academy

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
44 Years
Max Age
67 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-10
Primary Completion
2019-06-16
Completion
2019-12-20

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04239118 on ClinicalTrials.gov